AstraZeneca

Company

Investment-firm

Last deal

$1.5B
Local Amount - EUR 1.4B

Amount

Post-IPO Debt

Stage

30.07.2024

Date

3

all rounds

$5.3B

Total amount

General

About Company
AstraZeneca is a global biopharmaceutical company that develops innovative prescription medicines.

Related to

Investor AB

Investor AB

Investor AB is a leading VC that owns and invests in Nordic-based international companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Stockholm, Sweden

count Of Investments

18

count Of Exists

7

Industry

Sector :

Subsector :

Also Known As

AZ, Zeneca Group Plc

founded date

06.04.1999

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

AstraZeneca specializes in discovering, developing, manufacturing, and marketing prescription medicines that improve the health and quality of life for patients worldwide. Their focus is on creating medicines that are innovative, effective, and offer added benefits such as reduced side effects or improved treatment methods. They also strive to maximize the potential of every medicine they produce by exploring all possible uses and improvements. AstraZeneca's business strategy centers around delivering great medicines to patients through innovative science and global excellence in development and commercialization. Their goal is to transform the future of healthcare by harnessing the power of scientific advancements for the benefit of people, society, and the planet.
Contacts